The American and European strains of porcine reproductive and respiratory syndrome (PRRS) virus were initially isolated in an established cell line (CL 2621) and porcine alveolar macrophages (PAM), respectively. Subsequent isolation of American strains of this virus in PAM has also been reported. To determine their relative sensitivity for virus isolation, both PAM and CL 2621 cells were inoculated with 98 tissue specimens and 73 serum samples from animals suspected of having PRRS. Four of the 98 tissue samples yielded virus in both cell types, whereas 7 samples were positive only in PAM and 4 samples only in CL 2621. Of the 73 serum samples tested, 18 were positive in PAM of which only 2 were positive in CL 2621. Additionally, 82 isolates obtained initially in CL 2621 were inoculated in PAM cells, and 18 strains isolated originally in PAM were inoculated in CL 2621. Of the 82 CL 2621 isolates, 25 could not be propagated on PAM. Of the 57 that replicated in PAM, as detected by a positive test on indirect fluorescent antibody test, only 28 produced cytopathic effects and 29 did not. Of the 18 PAM isolates, 5 did not grow on CL 2621. Although PAM were relatively more sensitive for virus isolation, their failure to support the growth of certain strains of PRRS virus indicates the existence of variants among PRRS virus strains, and both PAM and CL 2621 should be used for virus isolation from clinical samples. In addition, the sensitivity of these 2 cell types was compared for the detection of fluorescent antibodies to PRRS virus using 179 serum samples from PRRS-infected animals. The results were comparable in both cell systems.
The porcine reproductive and respiratory syndrome (PRRS) has been affecting the US swine herds since 1987 5 . In 1990, a similar disease was reported in Europe, where it spread rapidly. The causative agent was first isolated in porcine alveolar macrophages (PAM) in The Netherlands and was designated as the Lelystad virus. 9 Shortly thereafter, a virus was isolated in an established cell line, CL 2621, in the USA and was designated as the ATCC VR-2332 isolate of PRRS virus. 3 Of the many cell systems tested, only PAM and CL 2621 support the replication of this virus. 1, 3, 9, 10 Several serologic tests have been developed for the detection of anti-PRRS antibodies. An immunoperoxidase monolayer assay (IPMA) was the first test developed 10 and has been used most commonly in Europe. An indirect fluorescent antibody (IFA) test using PAM 11 and CL 2621 cells 4 has been developed and is being used extensively in the USA. An immunoperoxidase test (IPT) and a virus neutralization (VN) test 1 using CL 2621 have also been developed, but the VN test is less sensitive than either the IFA test or the IPT From the Department of Veterinary Diagnostic Medicine (Bautista, Goyal, Collins) and Clinical and Population Sciences (Yoon, Joo) , College of Veterinary Medicine, University of Minnesota, St Paul, MN 55108.
Received for publication September 28, 1992. for the detection of antibody early in infection. 4 For this reason, the IFA test is now done on a routine basis in many laboratories, with some laboratories using PAM and the others using CL 2621 cells. The purposes of this study were to compare 2 cell systems, PAM and CL 2621, for the isolation of PRRS virus and for the detection of its antibody and to determine if isolates grown initially on 1 of the cell systems can be propagated in the other cell system.
Materials and methods
Cells. Porcine alveolar macrophages obtained from 4-8wk-old pigs were prepared as previously described. 9,10 The CL 2621 cells a were propagated in Eagle's minimum essential medium (MEM) supplemented with 10% beta propiolactonetreated fetal bovine serum (FBS) and 100 µg/ml of gentamicin.
Samples for virus isolation. A total of 171 samples (98 tissue samples and 73 serum samples) were tested. These specimens were from animals presented to the Minnesota Veterinary Diagnostic Laboratory for the diagnosis of possible PRRS virus infection. Before inoculation into cell cultures, tissue samples were homogenized in Hanks' balanced salt solution (HBSS) as a 10% suspension as previously described. 6 Serum samples were inoculated without any treatment. In addition, 82 strains of PRRS virus isolated originally on CL 2621 cells and 18 strains isolated originally in PAM were inoculated in PAM and CL 2621 cells, respec- and CL 2621 cells for the detection of anti-PRRS antibody.* tively, to determine if a strain propagated in 1 cell type would grow in the other cell type. The initial passage level of these strains on their respective cells was < 3. Virus isolation. Cell monolayers were prepared in 48-well microtiter plates. Each sample was inoculated in duplicate wells using 0.1 ml of sample per well. After 1 hr of adsorption, the cells were washed with HBSS followed by the addition of fresh MEM and incubation at 37 C for 7 days. The plates were observed daily for the appearance of cytopathic effects (CPE). A second passage was done using the cell supernatant, and in both passages, the cells were fixed with absolute ethanol and stained by IFA test using a polyclonal anti-VR 2332 antiserum b and a fluorescein-conjugated anti-porcine IgG c to confirm the presence of PRRS virus.
Samples for antibody detection. A total of 179 serum samples taken at different time intervals from 16 pigs experimentally infected with the MN-1b strain of PRRS virus were used to compare PAM and CL 2621 for the detection of anti-PRRS antibody. Four animals were infected with PRRS virus, followed by the placement of 4 animals each in contact with this group on days 3, 10, and 24 postinfection. Blood samples were obtained from all 16 animals between 9 and 17 times from days 0 to 49 postinfection.
Procedure for antibody detection. An IFA test was used for the detection of anti-PRRS antibody. Virus-infected cell monolayers were prepared in 96-well microplates. The PAM were infected with the MN-1b isolate of PRRS virus as previously described, 11 and 3-day-old CL 2621 cell monolayers were infected with the VR-2332 strain of PRRS virus using 1,000 TCID 50 of the virus per well. Following incubation at 37 C for 48 hr, the monolayers were fixed with cold ethanol and stored at -20 C until needed. Before use, ethanol was removed and the plates were air dried and washed with phos-phate-buffered saline (PBS). The test was performed as described previously. 11 Serial 4-fold dilutions of serum samples were made in PBS starting with a 1:16 dilution, and 0.1 ml of each serum dilution was placed in virus-infected well followed by incubation for 45 min at 37 C in a humid chamber. The plates were washed 3 times with PBS, followed by the addition of 50 µ1 of an appropriate dilution of a fluoresceinconjugated anti-porcine IgG per well. After another 45 min of incubation, the plates were washed again and observed under a fluorescent microscope for specific cytoplasmic/perinuclear fluorescence.
Results
Of the 98 tissue samples tested, 15 were positive for PRRS virus as detected by the production of CPE and/ or the detection of virus by the IFA test. Of these 15 isolates, 4 (26.7%) replicated only in CL 2621 cells, 7 (46.7%) only in PAM, and 4 (26.7%) replicated in both cell systems. Two of the 7 PAM-positive samples were lost on further passages on either cell system. Of the 73 serum samples tested, 18 were positive for PRRS virus; all 18 (100%) were positive on PAM, but only 2 (11%) were positive in CL 2621 cells (Table 1) . When 82 strains originally isolated in CL 2621 were inoculated on PAM, only 57 (69.6%) replicated; 28 (34.1%) were positive by CPE and IFA test, whereas 29 (35.4%) were negative for CPE but positive by IFA test ( Table 2) . Five of the 8 CPE-negative/IFA testpositive isolates became CPE positive/IFA test positive in second passage, whereas the remaining 3 isolates were lost on further passages. Of the 18 samples that were initially positive on PAM, 5 (27.8%) did not replicate when inoculated in CL 2621 cells.
Of the 179 serum samples examined for anti-PRRS antibody, 110 (6 1.5%) had the same titers in both cell types, 14 (7.8%) samples had higher titers in CL 2621 than in PAM, and 55 (30.7%) had higher titers in PAM than in CL 2621 (Table 3) .
